EUVIMEDSkopri EUVIMED
Crossref

Curcumin controls lysosomal acidification and exocytosis to ameliorate lysosomal cholesterol accumulation in Niemann–Pick type C disease

Hongyu Chen, Mengli Zhao, Yu Luo, Xiaohe Chu, Dan Li

British Journal of Pharmacology · 2026-08 · 183 (15) · 4305-4320

DOI: 10.1111/bph.70448 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2026-04-26. Written by Hongyu Chen and 4 co-authors. Institution: Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Techn…. Major MEDLINE topics: Lysosomes, Curcumin, Exocytosis, Cholesterol. Cited 1 times so far (Crossref); 66 references. Funded by: National Natural Science Foundation of China.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Purpose Niemann–Pick type C disease (NPCD) is a rare and fatal lysosomal storage disorder. There are limited therapies for NPCD, although multiple small‐molecule compounds have shown therapeutic potential for NPCD. Curcumin (CUR), a polyphenolic compound enriched in turmeric, has cholesterol‐lowering effects via regulating intestinal cholesterol absorption and liver cholesterol synthesis. CUR normalises sphingolipid trafficking and stimulates exosome/microvesicle release, increases cytosolic Ca 2+ levels, and enhances lysosomal activation via mTOR suppression and TFEB activation. How CUR specifically targets lysosomal cholesterol has not been fully clarified. Experimental Approach Effects of curcumin on lysosomal cholesterol accumulation were evaluated in NPC1 cell models. Filipin staining, immunofluorescence, surface LAMP1 and NAGase activity and Cathepsin B activity were investigated to evaluate lysosomal cholesterol, TFEB translocation, lysosomal exocytosis and hydrolytic activity. Lysosomal acidification was determined by Lysotracker Red, Oregon Green, and sfGFP/mCherry transfection. CRISPR/Cas9 and siRNA interference were used to investigate the role of TFEB/TFE3 and TRPML1 in curcumin‐induced cholesterol reduction. Key Results CUR alleviates lysosomal cholesterol accumulation in NPC1 cells in a TFEB‐ and TFE3‐dependent manner. CUR enhanced lysosomal acidity and promoted calcium‐dependent lysosomal exocytosis, which contributed to CUR‐mediated lysosomal cholesterol clearance. The combination of CUR with specific agonists (ML‐SAs) of MCOLN1/TRPML1, a lysosomal cation channel required for lysosomal exocytosis, improved lysosomal cholesterol clearance. Conclusion and Implications CUR reduces lysosomal cholesterol accumulation in NPC1 cells by activating TFEB/TFE3 pathways and promoting Ca 2+ ‐ and TRPML1‐dependent lysosomal exocytosis. These findings support curcumin and its analogues as potential therapeutics for NPCD and other diseases of lysosomal storage.

Subjects

MeSH terms (MEDLINE)

LysosomesCurcuminExocytosisCholesterolNiemann-Pick Disease, Type CHumansAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsNiemann-Pick C1 ProteinCell LineIntracellular Signaling Peptides and ProteinsMiceHydrogen-Ion Concentration

Author keywords

NPC1cholesterolcurcuminlysosomal acidificationlysosome exocytosis

Substances

CurcuminCholesterolBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsNiemann-Pick C1 ProteinIntracellular Signaling Peptides and Proteins

Authors and institutions

  • Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.
  • Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, Michigan, USA.

Funding

  • National Natural Science Foundation of China

Cite

APA

Chen, H., Zhao, M., Luo, Y., Chu, X., & Li, D. (2026). Curcumin controls lysosomal acidification and exocytosis to ameliorate lysosomal cholesterol accumulation in Niemann–Pick type C disease. British Journal of Pharmacology, 183(15), 4305-4320. https://doi.org/10.1111/bph.70448

Vancouver

Chen H, Zhao M, Luo Y, Chu X, Li D. Curcumin controls lysosomal acidification and exocytosis to ameliorate lysosomal cholesterol accumulation in Niemann–Pick type C disease. British Journal of Pharmacology. 2026;183(15):4305-4320. doi:10.1111/bph.70448

BibTeX
@article{Chen2026,
  author = {Chen, Hongyu and Zhao, Mengli and Luo, Yu and Chu, Xiaohe and Li, Dan},
  title = {Curcumin controls lysosomal acidification and exocytosis to ameliorate lysosomal cholesterol accumulation in Niemann–Pick type C disease},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {15},
  pages = {4305--4320},
  doi = {10.1111/bph.70448}
}
Start for free →